Regeneron Pharmaceuticals, Inc. earnings per share and revenue

REGN earnings per share for the last quarter are 9.55 USD whereas the estimation was 10.17 USD which accounts for -6.11% surprise. Företagets omsättning för samma period uppgår till 3.15 B USD trots den uppskattade siffran 3.23 B USD. Estimated earnings per share for the next quarter are 10.58 USD, and revenue is expected to reach 3.37 B USD. Also watch annual changes over time to get a bigger picture of REGN earnings per share and revenue dynamics.